Mainly company sponsored research.
- Co-investigator “9785-MA-1002 PREMISE”. Observationsstudie på enzalutamide (Xtandi) behandling.
- Co-investigator ”OX51-002”. Et randomiseret, placebo-kontrolleret forsøg til bestemmelse af dosis af tbl. Alfentanil, administreret under tungen, til lindring af smerter i forbindelse med udtagning af vævsprøver fra prostata, 2012.
- Co-investigator Phase III multicenter dobbelblinded randomized, placebo-controlled study: PROSPER
- Co-investigator Phase III multicenter dobbelblinded randomized, placebo-controlled study: PROSPECT
- Co-investigator Phase III multicenter dobbelblinded randomized, placebo-controlled study - now OPEN LABEL extention study: PREVAIL
- Co-investigator Phase II multicenter dobbelblinded randomized- now OPEN LABEL extention study: TERRAIN
- Co-investigator Phase II multicenter open label study: 9785-CL-0321
- Co-investigator Phase II multicenter dobbelblinded randomized study: CORAL
- Publications:
- “Pancreatitis acuta forårsaget af Ascaries lumbricoides” Ugeskr.Læger, 2000.
- “Idiopathic partial thrombosis of the corpus cavernosum - etiology, diagnosis and treatment". Manuscript ID SJUN-2012-0078
- ”Betydningen af testikulær microlithiasis”. Ugeskr Laeger 2014;176:V02130145
- Antibiotic prophylaxis for transrectal prostate biopsy-a new strategy: J Antimicrob Chemother, 2014
- UFL-03-16-0184.R1 - Et almindeligt kondom kan anvendes til at fjerne fastsiddende metalringe omkring penis
- Authorship:
- “Scrotums sygdomme”, Kirurgisk kompendium kittelbog, 3. udgave, 2011
Several of the studies above is still running.
Low dose brachytherapy for localized prostate cancer: survival and toxicity results from a single center.